PRA Health Sciences, Inc. Securities Litigation

Filing Deadline: July 25, 2021

If you purchased a significant amount of shares of PRA Health Sciences Inc. Common Stock (NASDAQ: PRAH), you have certain options. Investors should contact us before July 25, 2021.


Lawsuit Overview

Defendant:PRA Health Sciences Inc. Common Stock
Date Filed:May 26th, 2021
Sector:Health Care
Industry:Biotechnology: Commercial Physical & Biological Resarch
Class Start Date:February 24th, 2021
Class End Date:May 26th, 2021

On February 24, 2021, ICON plc issued a press release announcing that it had entered into an Agreement and Plan of Merger dated February 24, 2021 (the “Merger Agreement”) to acquire PRA Health. Under the terms of the Merger Agreement, each holder of PRA Health common stock will receive both of: (i) $80 in cash and (ii) 0.4125 shares of ICON common stock for each share of PRA Health common stock they own (the “Merger Consideration”).

On April 28, 2021, the Company filed a Schedule 14A Definitive Proxy Statement with the SEC. The Complaint alleges that the Proxy Statement, which recommends that PRA Health stockholders vote in favor of the Proposed Transaction, omits or misrepresents material information concerning, among other things: (i) certain financial projections; (ii) the data and inputs underlying the financial valuation analyses that support the fairness opinions provided by the Company’s financial advisors; and (iii) the Background of the Proposed Transaction.

Sign up for free to create a personalized portfolio with tracking and e-mail alerts for PRA Health Sciences Inc. Common Stock

First Identified Complaint

Michael Kent, et al. v. PRA Health Sciences, Inc., et al.

Date Filed:May 26th, 2021
Class Period Start:February 24th, 2021
Class Period End:May 26th, 2021
First Identified Complaint Filings
#Document TitleFiling Date